Prolonged survival after multimodal therapy for pleural mesothelioma: Don’t give up the follow-up. A case report
Annals of Medicine and Surgery 2020 November 11 [Link]
Julien Guinde, Bertrand Chollet, Sophie Laroumagne, Hervé Dutau, Philippe Astoul
Malignant Pleural mesothelioma (MPM) is a rare disease which is associated with a poor prognosis. Front line chemotherapy represents the cornerstone in the management of MPM, and the place of radical surgery is controversial and reserve in early-stage disease. However prolonged survival (more than 24 months) can be observed in rare cases and only in the context of multimodal treatment including surgical management. We report the case of a patient suffering from an epithelial MPM with a 14-years progression-free survival after trimodal treatment including extrapleural pneumonectomy followed by chemotherapy and radiotherapy. This case illustrates that despite being an aggressive disease, multimodal management including radical surgery may allow a prolonged response in MPM but requires a whole-life surveillance.